Diagnostic Imaging Pathways Logo

  • Pathways
  • Normal Anatomy
  • Medical Images
  • Radiation Module
  • Radiation Quiz
  • Menu
  • Search

Sinusitis (Chronic, Suspected)

Population Covered By The Guidance

This pathway provides guidance on the imaging of patients with chronic sinusitis.

Lead Researcher: Sian Chin

Experts & Contributors: Ravinder Dhillon, Peter Friedland, Andrew Thompson

Editorial Panel: Editorial Panel
Link to Editorial Panel

Date reviewed: July 2018

Date Published: March 2019

Image 1a, b and c (Computed Tomography): There is mucosal thickening of the right maxillary sinus with no bony obstruction or soft tissue changes. Associated with this is mucosal thickening of the right ostiomeatal complex. The left maxillary antrum and ostiomeatal complex are unremarkable.

Chronic Sinusitis

Image 1a, b and c (Computed Tomography): There is mucosal thickening of the right maxillary sinus with no bony obstruction or soft tissue changes. Associated with this is mucosal thickening of the right ostiomeatal complex. The left maxillary antrum and ostiomeatal complex are unremarkable.

Chronic Sinusitis

Image 1a, b and c (Computed Tomography): There is mucosal thickening of the right maxillary sinus with no bony obstruction or soft tissue changes. Associated with this is mucosal thickening of the right ostiomeatal complex. The left maxillary antrum and ostiomeatal complex are unremarkable.

Chronic Sinusitis

  • Chronic rhinosinusitis is a clinical diagnosis and is defined as rhinosinusitis lasting >12 weeks that includes two or more of the following signs and symptoms:
    • Mucopurulent drainage (anterior, posterior, or both)
    • Nasal obstruction (congestion)
    • Facial pain-pressure-fullness, or
    • Decreased sense of smell
    AND clinical diagnosis of chronic rhinosinusitis should be confirmed with objective evidence of sinonasal inflammation, either with anterior rhinoscopy, nasal endoscopy or radiographically
  • Plain radiography has limited value for imaging the paranasal sinuses and routine use is not indicated
  • CT without IV contrast is the imaging modality of choice
  • Significant unilateral disease is suspicious for neoplasm or inverted papilloma and warrants further evaluation

 

References are graded from Level I to V according to the Oxford Centre for Evidence-Based Medicine, Levels of Evidence. Download the document

    1. Kirsch CFE, Bykowski J, Aulino JM, Berger KL, Choudhri AF, Conley DB, et al. ACR appropriateness criteria((R)) sinonasal disease. J Am Coll Radiol. 2017;14(11s):S550-s9. (Guidelines). View the reference
    2. Setzen G, Ferguson BJ, Han JK, Rhee JS, Cornelius RS, Froum SJ, et al. Clinical consensus statement: appropriate use of computed tomography for paranasal sinus disease. Otolaryngol Head Neck Surg. 2012;147(5):808-16. (Guidelines). View the reference
    3. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, Brook I, Ashok Kumar K, Kramper M, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(2 Suppl):S1-s39. (Guideline). View the reference
    4. Kandukuri R, Phatak S. Evaluation of sinonasal diseases by computed tomography. Journal of Clinical and Diagnostic Research : JCDR. 2016;10(11):TC09-TC12. (Level II-III evidence). View the reference
    5. Holbrook EH, Brown CL, Lyden ER, Leopold DA. Lack of significant correlation between rhinosinusitis symptoms and specific regions of sinus computer tomography scans. Am J Rhinol. 2005;19(4):382-7. (Level II evidence). View the reference
    6. Falco JJ, Thomas AJ, Quin X, Ashby S, Mace JC, Deconde AS, et al. Lack of correlation between patient reported location and severity of facial pain and radiographic burden of disease in chronic rhinosinusitis. International forum of allergy & rhinology. 2016;6(11):1173-81. (Level II-III evidence). View the reference <
    7. Yeo NK, Park WJ, Ryu IS, Lim HW, Song YJ. Is facial or head pain related to the location of lesions on computed tomography in chronic rhinosinusitis?. Ann Otol Rhinol Laryngol. 2017;126(8):589-96. (Level II-III evidence). View the reference
    8. Greguric T, Trkulja V, Baudoin T, Grgic MV, Smigovec I, Kalogjera L. Association between computed tomography findings and clinical symptoms in chronic rhinosinusitis with and without nasal polyps. Eur Arch Otorhinolaryngol. 2017;274(5):2165-73. (Level II evidence). View the reference
    9. Stewart MG, Sicard MW, Piccirillo JF, Diaz-Marchan PJ. Severity staging in chronic sinusitis: are CT scan findings related to patient symptoms? Am J Rhinol. 1999;13(3):161-7. (Level II-III evidence). View the reference
    10. Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology. 1993;31(4):183-4. (Level II-III evidence). View the reference
    11. Hopkins C, Browne JP, Slack R, Lund V, Brown P. The Lund-Mackay staging system for chronic rhinosinusitis: how is it used and what does it predict? Otolaryngol Head Neck Surg. 2007;137(4):555-61. (Level II evidence). View the reference
    12. Aribandi M, McCoy VA, Bazan C. Imaging features of invasive and noninvasive fungal sinusitis: a review. Radiographics. 2007;27(5):1283-96. (Review article). View the reference
    13. Joshi VM, Sansi R. Imaging in sinonasal inflammatory disease. Neuroimaging Clin N Am. 2015;25(4):549-68. (Review article). View the reference

Pathway User Guide

Yellow Boxes Denotes extra information. Some contain single or multiple white sub-boxes, click a white box to reveal detailed information in a pop-up.

White Boxes: Denotes standard pathway steps. (If inside a yellow box, they open a specific pop-up).

Zoom & Pan Controls: Use + / − or the slider to zoom. Reset returns to default. Tick Panning to drag the diagram when zoomed.

Blue “View Full Screen” Button: Opens the whole diagram in a large, full-screen pop-up window. Use Close to exit.

The relative radiation level (RRL) of each imaging investigation is displayed in the pop up box.

SYMBOL RRL EFFECTIVE DOSE RANGE
No radiation None 0
Minimal radiation Minimal < 1 millisieverts
Low radiation Low 1-5 mSv
Medium radiation Medium 5-10 mSv
High radiation High >10 mSv

Disclaimer

Status Of Recommendations Each pathway is designed to assist clinicians in situations when faced with a large array of possible diagnostic tests and examinations. However, it is recognised that diagnostic practice may differ from a particular pathway depending on local availability of equipment and expertise, as well as the experience of individual clinicians. Therefore each pathway is neither a rigid set of rules, nor a substitute for clinical assessment, and individual patient circumstances should always be considered.

Report an Issue

Spotted an error or outdated info? Click to tell us.

SUSPECTED CHRONIC RHINOSINUSITIS 2 or more signs or symptoms lasting >12 weeks:- Mucopurulent drainage (anterior, posterior, or both)- Nasal obstruction (congestion) - Facial pain-pressure-fullness, or- Decreased sense of smell Objective confirmation of clinical diagnosis Non-contrast CT Anterior rhinoscopy or nasal endoscopy Imaging indicated: - For surgical planning - If clinical examination is normal but there is ongoing high suspicion for CRS Manage findings appropriately, which may include ENT referral if not already done Normal Significant unilateral disease Consider alternate diagnosis Immediate ENT referral indicated Date reviewed: July 2018 Please note that this pathway is subject to review and revision

SUSPECTED CHRONIC RHINOSINUSITIS

SUSPECTED CHRONIC RHINOSINUSITIS

Computed Tomography (CT)

Coronal non-contrast CT scan

Imaging modality of choice to objectively confirm the clinical diagnosis of chronic rhinosinusitis

  • CT without contrast is the imaging modality of choice for evaluating chronic rhinosinusitis
  • Role of CT:
    • Objective confirmation of the clinical diagnosis; anterior rhinoscopy or nasal endoscopy may also be used
    • Surgical planning
    • Screen for other causes for symptoms such as neoplasm or atypical infections
    • Assess for complications
  • CT has a high false positive rate and up to 40% of asymptomatic adults will demonstrate abnormalities on sinus CT and imaging findings correlate poorly with symptom location and severity, so the diagnosis of chronic rhinosinusitis requires clinical criteria as well as objective evidence
  • The Lund-Mackay score is a simple tool to assess the extent of disease in chronic rhinosinusitis based on sinus opacification. It has been proposed that patients undergoing endoscopic sinus surgery should have a minimum score of 4. There is usually involvement of multiple sinuses, if not pansinusitis and rhinitis
  • Other findings in chronic rhinosinusitis are diverse which include mucosal thickening, sclerosis of bony walls and intrasinus calcifications
  • Magnetic resonance imaging may be useful in the specialist evaluation of complicated sinusitis, intraorbital and intracranial manifestations of aggressive sinusitis, and sinonasal neoplasms

  • Acute Abdomen
  • Breast
  • Cancer Staging
  • Cardiovascular
  • Ear, Nose & Throat
  • Endocrine
  • Gastrointestinal
  • Kidney and Urinary Tract
  • Liver and Biliary
  • Musculoskeletal Non-Trauma
  • Neurological
  • Obstetric & Gynaecological
  • Paediatric
  • Pancreas
  • Respiratory
  • Trauma
    • Trauma - Musculoskeletal
    • Trauma - Head
    • Trauma - Visceral
    • Trauma - Paediatric
  • Ear Nose & Throat

    • Ear, Nose & Throat
      • Laryngeal Cancer (Staging)
      • Salivary Gland Swelling
      • Sinusitis (acute)
      • Sinusitis (Chronic, Suspected)
      • Tinnitus
      • Vertigo (Recent Onset)

    Diagnostic Imaging Pathways

    The DIP pathways are a step-by-step guides to help clinicians choose the most appropriate imaging for each clinical scenario 

    “Trusted by clinicians worldwide since 2007, Diagnostic Imaging Pathways provides clear, evidence-based imaging guidelines. Our pathways support better decision-making and help improve healthcare outcomes—especially in emerging nations. 

    DIP functions and thrives wholeheartedly under the pillars of diversity, inclusivity and respect for all."

    • Pathways
    • Normal Anatomy
    • Medical Images
    • Radiation Module
    • Radiation Quiz
    • Information for Consumers
    • Governance
    • About Imaging
    • Production
    • Search
    • Login
    • Get in Touch
    © Diagnostic Imaging Pathways (DIP) 2025
    Code of Conduct    Terms and Conditions of Use
    General Site Navigation

    Information For Consumers

    • General Information About Diagnostic Imaging
      • Colorectal (Bowel) Cancer Screening
      • Colorectal (Bowel) Cancer Screening (Australia)
      • Consent to Procedure or Treatment
      • Radiation Risks of X-rays and Scans
    • Imaging Pathways
      • Ankle Injury (Suspected)
      • Bowel Cancer (Staging)
      • Deep Venous Thrombosis ( Leg, Suspected)
      • Deep Venous Thrombosis (Arm, Suspected)
      • Headache (Constant or Repeated)
      • Hip Fracture (Suspected)
      • Hypertension
      • Low Back Pain (Acute)
      • Lung Cancer (Staging)
      • Neck Pain (Non-Traumatic)
      • Renal Colic
      • Respiratory Illness (Acute)
      • Scaphoid Fracture (Suspected)
      • Shoulder (Pain or Instability)
      • Sinusitis (Acute)
      • Sinusitis (Chronic)
      • Stress Fracture (Suspected)
    • Imaging Procedures
      • Angiography (Angiogram)
      • Arthrogram
      • Bone Scan
      • Computed Tomography (CT)
      • Computed Tomography (CT) Angiography
      • Inferior Vena Cava (IVC) Filters
      • Intravenous Pyelogram (IVP)
      • Magnetic Resonance Angiography (MRA)
      • Magnetic Resonance Imaging (MRI)
      • Myelogram
      • Orthopantomogram (OPG)
      • Percutaneous Transthoracic Fine Needle Aspiration (FNA) or Biopsy
      • Positron Emission Tomography (PET)
      • Renal Artery Angioplasty and Stent
      • Renal Scan
      • Ultrasound
      • Ultrasound (Doppler)
      • Ultrasound (Endoscopic Rectal)
      • Venography (Venogram)
      • X-ray (Chest)
      • X-ray (Plain Radiograph)

    Governance

    • History
      • 1990s to 2012
      • 2012 to 2016
      • 2016 to 11 April 2022
      • From 12 April 2022
      • Introduction
      • List of acronyms used on this site
    • Organisation
      • 2003 - 2012
      • 2013 - 2016
      • 2017 - 11 April 2022
      • Post 12 April 2022
    • Personnel
      • Clinical Advisors
      • Contractors
      • Contributors
      • Editor
      • Editorial Panel - Post 2022
      • Editorial Panel - Pre 2022
      • Executive Sponsor
      • Information Technologist
      • Manager
      • Other Personnel
      • Project Officers
      • Quality Coordinator
      • Research Registrar
      • Responsibilites
      • Steering Committee
      • Steering Committee
    • Responsibilities, Achievements
      • Accreditation and Endorsement
      • Clinical Advisors
      • Editor
      • Editorial Panel
      • Executive Sponsor
      • Information Technologist
      • Manager
      • Other Personnel
      • Pathway Creation, Review and Revision
      • Quality Coordinator
      • Research Registrar
      • Steering Committee

    About Imaging

    • About Imaging
      • Bleeding Risk and Assessment
      • General Principles in Requesting and Providing Imaging Investigations
      • Imaging During Pregnancy and Lactation
      • Ionising Radiation in Diagnostic Imaging
      • Ionising Radiation in Paediatric Imaging
    • Common Procedures
      • Computed Tomography
      • Gastrointestinal Contrast Examinations
      • High Resolution Computed Tomography
      • Magnetic Resonance Imaging
      • Nuclear Medicine
      • Positron Emission Tomography
      • Ultrasound
    • Contrast Agents
      • Gadolinium Contrast for MRI scans
      • Iodinated Contrast for CT scans
      • Ultrasound Contrast Media

    Production

    • Editorial Independence
      • Disclosure of Conflict of Interest
      • Funding Policy & Sources
      • Management of Conflict of Interest
    • Processes for Creating and Managing Content
      • Creation of a New Pathway
      • Creation of New Information for Consumers
      • Review and Revision of a Pathway
      • Review and Revision of Information for Consumers
    • Production
      • Initial Engagement with Consumers
      • Principles for Creating and Managing Content